Angiosarcomas of the head and neck: Impact of large data analysis on clinical management

J Oral Pathol Med. 2022 Nov;51(10):904-910. doi: 10.1111/jop.13354. Epub 2022 Sep 20.

Abstract

Angiosarcoma is a rare but often fatal malignancy from blood and lymphatic vessels that can arise anywhere in the body and often affects the head and neck region. Although its dismal prognosis is predominantly explained by its aggressive biology, several secondary factors contribute to poor outcomes. These include a phenotypic resemblance to innocuous blood vessel lesions, which contributes to a significant degree of late diagnosis. Another important factor is the rarity of angiosarcoma, which has impaired scientific determination of its optimal treatment significantly. As a result, treatment of angiosarcomas has largely been guided by information derived from the study of sarcomas at large, themselves a highly heterogeneous group of mesenchymal cancers both from a diagnostic as well as therapeutical perspective. The Digital Revolution and resultant Information Age promise to transform the clinical management of rare cancers from a generic to a more customized approach. In this paper, we review the current understanding of head and neck angiosarcomas within the context of this process.

Keywords: angiosarcoma; head and neck; outcomes; review.

Publication types

  • Review

MeSH terms

  • Data Analysis
  • Head and Neck Neoplasms* / diagnosis
  • Head and Neck Neoplasms* / pathology
  • Head and Neck Neoplasms* / therapy
  • Hemangiosarcoma* / diagnosis
  • Hemangiosarcoma* / pathology
  • Hemangiosarcoma* / therapy
  • Humans
  • Neck / pathology
  • Prognosis
  • Sarcoma*